Клиномир в тестовом запуске. Кто с нами с первых дней, получит отметку «С первых дней» в профиле и первым увидит новые возможности сайта.

Зарегистрироваться
Статус неизвестен Россия

G17032022

Innovative Technologies in Restoring Gait and Balance Functions in Patients in Acute and Early Recovery Periods of Ischemic Stroke at the Inpatient Stage of Medical Rehabilitation

Номер протоколаG17032022
ФазаФаза не указана
Участников по плану — во всех странах исследования120
Сроки18.03.2022 — 31.12.2023
Начало: 18 марта 2022Окончание: 31 декабря 2023
Плановый срок исследования истёк

Постоянная ссылка: https://clinomir.ru/trials/nct/NCT05423626/

Источник: ClinicalTrials.gov (U.S. National Library of Medicine). Что откуда

Простыми словами

Словарь терминов
  • Статус исследования в реестре не указан — уточняйте в центре.
  • Возраст участников: 19–75 лет. Остальные условия — в блоке «Кто может участвовать».
  • По плану участвуют 120 чел. во всех странах исследования.
  • Центров в реестре: 1 в одном городе. Список — ниже на странице.
  • Плановая дата окончания (12.2023) уже прошла.

Пересказ собран автоматически из данных реестра, без оценки пользы и рисков. Подробно о рисках и пользе рассказывает врач центра перед подписанием согласия.

Кто может участвовать

Возраст19–75 лет
ПолЛюбой
Здоровые добровольцынет
Полный текст критериев (на английском, как в ClinicalTrials.gov) · включение: 10 · невключение: 34

Критерии включения

  • Availability of signed informed consent
  • Patients with ischemic stroke in the acute and early recovery period, from 5 days to 6 months after the stroke.
  • Men and women from 19 to 75 years old.
  • The ability to be in a standing position without a pronounced decrease in blood pressure (at least 15 minutes).
  • For stroke patients, the score on the scale of muscle strength in the lower extremities is 0-4 points.
  • Weight not more than 100 kg
  • Height from 160 to 190 cm .
  • High motivation for recovery
  • Preservation of cognitive functions (at least 27 points on MoCA)
  • Rating on the Rankin scale 3-4 points-

Критерии невключения

  • Refusal of the patient to sign an informed consent to participate in the study and refusal to cooperate;
  • Inability to be in a standing position (less than 15 minutes), due to pathological vegetative reactions (orthostatic hypotension, tachycardia, bradycardia, arrhythmia, etc.);
  • Pregnant, lactating women and women planning pregnancy
  • The severity and instability of the somatic condition that prevents verticalization, the presence of contraindications for physical exertion and walking.
  • Acute infectious diseases, febrile syndrome;
  • Availability of pacemakers;
  • Blood pathologies;
  • Active form of rheumatism
  • Condition after stitching of muscles, tendons, nerves
  • Chronic diseases in the decompensation stage;
  • Severe vegetative dysreflexia, uncontrolled arterial hypertension (AD system. more than 180 mm Hg, AD diast. more than 100 mm Hg);
  • Attacks of angina pectoris at rest or ECG-signs of myocardial ischemia at rest;
  • Myocardial infarction less than 6 months ago;
  • Heart defects;
  • Paroxysmal and persistent form of atrial fibrillation;
  • Sinus bradycardia (less than 50 beats per minute) and tachycardia (more than 90 beats per minute). At rest and more than 130 beats . in min. under load);
  • Atrioventricular block of I-III degree;
  • Acute venous thrombosis and / or thrombophlebitis of any localization, edema of the lower extremities 2-3 art.
  • Circulatory insufficiency above functional class II according to NYHA
  • Aneurysm of the aorta and cerebral arteries;
  • Hypercoagulation, erythrocytosis.
  • Decompensation of diabetes mellitus.
  • Trophic disorders - bedsores in the places of attachment of the exoskeleton;
  • Epilepsy and other paroxysmal disorders of consciousness;
  • Ankylosis, fixed contractures, deforming arthrosis 3-4 ct, arthritis/synovitis, condition after endoprosthetics, arthroplasty of the joints of the lower extremities;
  • Ungrown fractures or unstable osteosynthesis of the spine, pelvic bones, lower extremities;
  • Instability (subluxations and dislocations) in the joints of the legs
  • Pronounced muscle spasticity (more than 3 points) or significant growth after training;
  • Osteoporosis
  • Systemic connective tissue diseases
  • Malignant tumors.
  • Motor and sensory aphasia
  • Cognitive impairment (less than 26 points on MoCA)
  • Increasing/persistent compression of the spinal cord, its roots, ponytail or ves

Источник: ClinicalTrials.gov, NCT05423626 · запись обновлена в реестре 21 июня 2022.

Дизайн и результаты

ДизайнРандомизированное, простое слепое, параллельные группы; цель — лечение
Участников по плану (все страны)120
Результатыбудут после окончания
Что измеряют — первичные конечные точки (8), вторичных — 5
  • Changes of Life quality assessment — Baseline, day 14 after completing training
  • Hauser Ambulation index dynamic — Baseline, day 14 after completing training
  • Change from Baseline in Tinetti test — Baseline, day 14 after completing training
  • The Rivermead Mobility Index dynamic — Baseline, day 14 after completing training
  • The Tampa Scale of Kinesiophobia dynamic — Baseline, day 14 after completing training
  • The Modified Rankin Scale dynamic — Baseline, day 14 after completing training
  • Change in MRC scale for muscle power — Baseline, day 14 after completing training
  • Change in modified Ashworth scale — Baseline, day 14 after completing training

Цель исследования

The scientific hypothesis was based on data on the effectiveness of the usage of robotic mechanotherapy and virtual reality technologies. Purpose of the study is the development and scientific substantiation of the effectiveness and safety of rehabilitation programs using the technology of robotic mechanotherapy (exoskeleton) with functional electrical stimulation (FES) and virtual reality (VR) technology with biofeedback (BFB) in restoring walking and balance disorders at the stationary stage of medical rehabilitation in patients in acute and early recovery periods of ischemic stroke. The duration of the study is 2 years. The study is planned to include 120 patients. Anamnesis collection, physical and neurological examination will be carried out for all patients upon admission. Diagnostic transcranial magnetic stimulation, electroencephalography and stabilometry will also be performed upon admission and discharge. Adverse events will be assessed. On the last day of the study, the dynamics of the volume and strength of movements, functional independence and spasticity will be assessed according to the scales (MRC, NIHSS, mAS, mRS, Rivermead, Hauser walking index, Tinetti scale, SHRM, ICF, Tampa scale, EQ-5D-5L), as well as the assessment of mental and cognitive status according to HADs and MoCA. Patients will be randomly divided into 4 groups: 3 main and 1 control. All patients will undergo a basic rehabilitation course. In the first group (exoskeleton with FES): 10 procedures, 5 times a week, the duration of the course of medical rehabilitation is 12-14 days. The total duration of one procedure is 1 hour. In the second group (VR technologies with BFB): 10 procedures, 5 times a week, the duration of the course of medical rehabilitation is 12-14 days. The total duration of one procedure is 30 minutes. In the third group (Complex application of robotic mechanotherapy technologies with FES and VR with biofeedback): 10 procedures, 5 times a week, the duration of the course of medical rehabilitation is 12-14 days. The total duration of training with VR is 30 minutes, then no earlier than 2 hours later, training on an exoskeleton, lasting no more than 1 hour. Patients in the control group will receive comprehensive rehabilitation procedures as prescribed, during the course of treatment accepted in a medical institution.

Где проходит

1 центр в 1 городе

Откуда эта информация

  • ClinicalTrials.gov (U.S. National Library of Medicine) · NCT05423626 Официальный реестр (США) · загружено 9 ноября 2026
    Номер протокола, название, цель, сроки, число участников, спонсор, центры

Сведения сведены и нормализованы порталом «Клиномир»: названия компаний и центров приведены к одному написанию. Нашли ошибку? Напишите нам — исправим.

Изменения не сохранены

На этой странице есть несохранённые изменения. Если уйти со страницы, они пропадут.